Close Menu

NEW YORK (GenomeWeb) – Macrogen and Silicon Biosystems Menarini announced today that they are partnering to co-develop CLIA-certified genomic tests for different cancers.

The companies plan to combine Silicon Biosystems' DEPArray digital-sorting technology with Macrogen's high-throughput whole-genome, whole-exome, and targeted sequencing systems to resolve cellular heterogeneity of formalin-fixed paraffin-embedded (FFPE) biopsies and fine-needle aspiration (FNA) samples.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

People reports that researchers have uncovered genetic variants that lead people to always feel full.

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.